TY - JOUR
T1 - Molecular mechanisms defining penetrance of LRRK2-associated Parkinson's disease
AU - Trinh, Joanne
AU - Schymanski, Emma L.
AU - Smajic, Semra
AU - Kasten, Meike
AU - Sammler, Esther
AU - Grünewald, Anne
N1 - Funding Information:
JT, MK and AG obtained funding from the German Research Foundation (‘ProtectMove’; FOR 2488). JT is the recipient of funding from the Canadian Institutes of Health Research (CIHR) (FRN152440), the Peter and Traudl Engelhorn Foundation and the Joachim Herz Stiftung (850022). ELS acknowledges funding support from the Luxembourg National Research Fund (FNR) for project A18/BM/12341006. SS received funding from the FNR within the PARK-QC DTU (PRIDE17/12244779/PARKQC). MK was supported within the framework of the Lübeck International Parkinson Disease (LIPAD) study funded by Centogene Rostock. ES was supported by grants from the Michael J. Fox Foundation (MJFF-019271) and Tenovus Scotland as well as a Senior Clinical Academic Fellowship from CSO NHS Research Scotland. AG was funded by the FNR within the ATTRACT (‘Model-IPD’, FNR9631103) and INTER programs (‘ProtectMove’, INTER/DFG/19/14429377). The funding organization(s) played no role in the study design; in the collection, analysis, and Interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
PY - 2022/8/31
Y1 - 2022/8/31
N2 - Mutations in Leucine-rich repeat kinase 2 (LRRK2) are the most frequent cause of dominantly inherited Parkinson's disease (PD). LRRK2 mutations, among which p.G2019S is the most frequent, are inherited with reduced penetrance. Interestingly, the disease risk associated with LRRK2 G2019S can vary dramatically depending on the ethnic background of the carrier. While this would suggest a genetic component in the definition of LRRK2-PD penetrance, only few variants have been shown to modify the age at onset of patients harbouring LRRK2 mutations, and the exact cellular pathways controlling the transition from a healthy to a diseased state currently remain elusive. In light of this knowledge gap, recent studies also explored environmental and lifestyle factors as potential modifiers of LRRK2-PD. In this article, we (i) describe the clinical characteristics of LRRK2 mutation carriers, (ii) review known genes linked to LRRK2-PD onset and (iii) summarize the cellular functions of LRRK2 with particular emphasis on potential penetrance-related molecular mechanisms. This section covers LRRK2's involvement in Rab GTPase and immune signalling as well as in the regulation of mitochondrial homeostasis and dynamics. Additionally, we explored the literature with regard to (iv) lifestyle and (v) environmental factors that may influence the penetrance of LRRK2 mutations, with a view towards further exposomics studies. Finally, based on this comprehensive overview, we propose potential future in vivo, in vitro and in silico studies that could provide a better understanding of the processes triggering PD in individuals with LRRK2 mutations.
AB - Mutations in Leucine-rich repeat kinase 2 (LRRK2) are the most frequent cause of dominantly inherited Parkinson's disease (PD). LRRK2 mutations, among which p.G2019S is the most frequent, are inherited with reduced penetrance. Interestingly, the disease risk associated with LRRK2 G2019S can vary dramatically depending on the ethnic background of the carrier. While this would suggest a genetic component in the definition of LRRK2-PD penetrance, only few variants have been shown to modify the age at onset of patients harbouring LRRK2 mutations, and the exact cellular pathways controlling the transition from a healthy to a diseased state currently remain elusive. In light of this knowledge gap, recent studies also explored environmental and lifestyle factors as potential modifiers of LRRK2-PD. In this article, we (i) describe the clinical characteristics of LRRK2 mutation carriers, (ii) review known genes linked to LRRK2-PD onset and (iii) summarize the cellular functions of LRRK2 with particular emphasis on potential penetrance-related molecular mechanisms. This section covers LRRK2's involvement in Rab GTPase and immune signalling as well as in the regulation of mitochondrial homeostasis and dynamics. Additionally, we explored the literature with regard to (iv) lifestyle and (v) environmental factors that may influence the penetrance of LRRK2 mutations, with a view towards further exposomics studies. Finally, based on this comprehensive overview, we propose potential future in vivo, in vitro and in silico studies that could provide a better understanding of the processes triggering PD in individuals with LRRK2 mutations.
KW - Environment
KW - Genetic modifiers
KW - LRRK2
KW - Mitochondria
KW - Parkinson's disease
KW - Penetrance
KW - Rab signalling
KW - Toxin exposure
UR - http://www.scopus.com/inward/record.url?scp=85135962933&partnerID=8YFLogxK
U2 - 10.1515/medgen-2022-2127
DO - 10.1515/medgen-2022-2127
M3 - Article
AN - SCOPUS:85135962933
SN - 0936-5931
VL - 34
SP - 103
EP - 116
JO - Medizinische Genetik
JF - Medizinische Genetik
IS - 2
ER -